Lifearc

1-1 of 1 Articles
Clock icon 2 minutes

Pheno Therapeutics, a new drug-discovery spin-out from the University of Edinburgh, has been launched with the backing of Series A funding totalling £5 million from Advent Life Sciences, the Scottish Investment Bank and LifeArc. With the £5m funding spanning over its first three years, P

1-1 of 1 Articles